Chinese vaccine maker Cansino Biologics’ shares soared as much as 52% in Hong Kong to hit HK$133. Its shares on the Star Market in Shanghai are surging by the daily limit of 20% to hit 253.5 yuan.
After China’s financial hub of Shanghai became the first city in the country to provide Cansino’s inhaled COVID-19 vaccine boosters, 13 cities in the neighbouring Jiangsu province have also started to prepare for using the inhaled vaccine booster, according to information from local health authorities.
The city of Wuxi, Huaian and Yangzhou, in Jiangsu, have taken a lead in offering Cansino’s inhaled vaccine to residents.
In what is believed to be a world first, Shanghai last week introduced a new type of COVID-19 vaccine that is inhaled rather than administered via injection. Chinese regulators approved the vaccine, produced by Chinese pharmaceutical firm CanSino Biologics, for use as a booster in September.
